Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers
Article in Clinical and Translational Science (September 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia
Article in International Journal of Molecular Sciences (March 2024)
Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective
Article in Critical Reviews in Oncology/Hematology (February 2024)